Statistics for Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: a real-life data of Turkish Oncology Group
Total visits
| views | |
|---|---|
| Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: a real-life data of Turkish Oncology Group | 0 |
Total visits per month
| views | |
|---|---|
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |